YBX1 and neoplasm: TET2’s oxidation weakens YBX1’s binding affinity to mRNA because YBX1’s recognition ability for 5hmC-modified mRNA is weaker than that for 5mC, thus indirectly inhibiting YBX1’s function by weakening its binding to target mRNA, thereby reducing mRNA stability and inhibiting tumor development.